- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04744038
Evaluating the Efficacy of PAP Therapy for Treating OSA in the Home Environment
Evaluating the Efficacy of Positive Airway Pressure Therapy for Treating Obstructive Sleep Apnea in the Home Environment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A new PAP device has been developed by ResMed which includes an improved humidification system, a new user interface and optimized workflows. This study will assess the efficacy and usability of the new PAP device in an OSA population.
This is a prospective, open-label, single arm study, multi-site study to assess the usability and efficacy of investigational device in the home environment.
Recruitment Recruitment will be done via phone calls/ SMS messages/ emails. Participants will be explained the details of the study and those who wish to take part will be invited to a ResMed clinic or selected site for the first study visit (As detailed in section 7).
Visit 1 Participants will provide written informed consent (as per section 6.1). If eligible, baseline participant demographics will be collected. Participants will be shown the investigation device. If the participant is happy to proceed the investigational device will be set-up to be exactly the same as their current CPAP device, and the participant will take it home to use in place of their own device.
Visit 2 At the conclusion of the 7 nights of use, the participant will be asked to fill in a questionnaire documenting their experience with the investigational device. The participant will return all study equipment to the researcher. The questionnaires will be reviewed. This concludes the participation in the study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2153
- ResMed BELLA VISTA
-
-
-
-
California
-
San Diego, California, United States, 92123
- Sleep Data
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients willing to give written informed consent
- Patients who can read and comprehend English
- Patients who ≥ 18 years of age
- Patients being established on PAP therapy for the treatment of OSA for ≥ 6 months
- Patients currently using AirSense10 (as their primary device)
- Patients currently using an appropriate mask system (AirFit F20, AirFit P10, AirFit N20, AirFit N30i, AirFit F30i or AirFit P30i)
- Patients who can trial the investigational device for up to 7 nights
- Patients who have been compliant to therapy (average of ≥4 hours of usage) for the previous 7 nights of use* *the most recent consecutive 7 nights within the last 30 days
Exclusion Criteria:
- Patients using Bilevel flow generators
- Patients who are or may be pregnant
- Patients with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury.
- Patients believed to be unsuitable for inclusion by the researcher
- Patients who or whose bed partner has implantable metallic implants in the head, neck and chest region affected by magnetic fields (Non-ferrous implants may be acceptable)
- Patients using supplemental oxygen
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Investigational Device
Participants will then be asked to take home the investigational device to use at night while they sleep in place of their own device.
The participant's therapy and comfort settings will be copied from their own device to the investigational device.
Participants will use their own mask with the investigational device for the duration of this study.
|
PAP therapy supplies pressurized air from the flow generator to the upper airway via air tubing and a mask to prevent the repetitive collapse of the upper airway during sleep.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Usability
Time Frame: 1 week
|
Subjective ratings of the Usability of the Pacific device after using it in the home environment for up to 7 nights.
Ratings will be collected using an 11 point Likert Scale where a score of 10 is considered very favorable, and a score of 0 is very unfavorable.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Apnea Hypopnea Index (AHI)
Time Frame: 1 week
|
Number of residual Apnea Hypopnea events within a clinically acceptable range when using the Pacific device in the home environment for a up to 7 nights.
|
1 week
|
Usage-Positive Airway Pressure (PAP) Device parameters
Time Frame: 1 week
|
Average number of hours per night of use of the Pacific Device during sleep sessions from up to 7 nights
|
1 week
|
Leak-Positive Airway Pressure (PAP) Device parameters
Time Frame: 1 week
|
Average median, 95 percentile and maximum leak(L/min) while using the Pacific device from up to 7 nights
|
1 week
|
Pressure-Positive Airway Pressure (PAP) Device parameters
Time Frame: 1 week
|
Average pressure delivered by the Pacific device between 4cmH2O-20cmH2O from use up to 7 nights
|
1 week
|
Acoustic Signals
Time Frame: 1 week
|
Cross-correlation of the acoustic signals recorded from the patient environment and the external recording in the controlled laboratory environment identification algorithm.
|
1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SLP-20-01-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea (OSA)
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
Hospital for Special Surgery, New YorkCompletedObstructive Sleep Apnea (OSA)
-
Mayo ClinicCompletedObstructive Sleep Apnea (OSA)United States
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
ApnimedCompletedOSA - Obstructive Sleep ApneaUnited States
-
Tufts Medical CenterRespiratory Motion, Inc.Active, not recruitingObstructive Sleep Apnea (OSA)United States
-
Weill Medical College of Cornell UniversityTerminatedObstructive Sleep Apnea (OSA)United States
-
Weill Medical College of Cornell UniversityCornell UniversityWithdrawn
-
ResMedCompletedObstructive Sleep Apnea (OSA)Australia
Clinical Trials on Positive Airway Pressure (PAP) Therapy
-
ResMedSingapore General HospitalNot yet recruitingObstructive Sleep Apnea
-
ResMedUnknownObstructive Sleep Apnea (OSA)Australia
-
University of MiamiNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingObstructive Sleep ApneaUnited States
-
University of CreteCompletedObesity Hypoventilation Syndrome
-
University of CreteCompleted
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | PreeclampsiaUnited States
-
VA Office of Research and DevelopmentRecruitingObstructive Sleep Apnea | Substance Use Disorder | Post Traumatic Stress Disorder | Residential Treatment ProgramUnited States
-
Philips RespironicsCompletedObstructive Sleep Apnea | Cheyne-Stokes Respiration | Sleep Apnea CentralUnited States
-
University of MichiganNational Multiple Sclerosis SocietyCompleted
-
Dr John KimoffCanadian Institutes of Health Research (CIHR); ResMed Canada Inc.CompletedSleep Apnea, Obstructive | Hypertensive Disorder of PregnancyCanada